Benitec Biopharma Limited (BLT.AX)


ASX - ASX Delayed Price. Currency in AUD
0.09+0.00 (+5.62%)
At close: 7:59 PM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.09
Prev Close0.09
Bid0.00 x
Ask0.00 x
Day's Range0.09 - 0.09
52wk Range0.09 - 0.56
1y Target EstN/A
Market Cap13.77M
P/E Ratio (ttm)-0.54
BetaN/A
Volume8,850
Avg Vol (3m)247,329
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • PR Newswire2 months ago

    Benitec announces restructuring of Senior Executive team

    NASDAQ: BNTCW) announces the appointment of Mr Greg West as Chief Executive Officer, Dr Cliff Holloway to the combined role of Chief Business and Operating Officer and Mr Bryan Dulhunty as Chief Financial Officer.

  • PR Newswire4 months ago

    Benitec Biopharma Interim Report for the Nine Months Ended March 31, 2016

    SYDNEY, May 24, 2016 /PRNewswire/ -- Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today lodged its Interim Report for the nine months ended March 31, 2016. The report includes the ...

  • Reuters4 months ago

    European shares end little changed; Taylor Wimpey, Vodafone rise

    Taylor Wimpey advanced 4.7 percent after the housebuilder announced a new special payout, promising investors about 1.3 billion pounds over three years, underpinned by strong demand for property in Britain. Vodafone rose 1.5 percent after the world's second-largest mobile phone operator said its earnings growth would accelerate this year.